Evidence map›Paper›PMID 30523270›Full record

ArticleScientific reports2018

Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.

Markus Eckstein, Rudolf Jung, Katrin Weigelt, Danijel Sikic, Robert Stöhr, Carol Geppert, Abbas Agaimy, Verena Lieb, Arndt Hartmann, Bernd Wullich and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Markus EcksteinInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Rudolf JungInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Katrin WeigeltDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Danijel SikicDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Robert StöhrInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Carol GeppertInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Verena LiebDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Arndt HartmannInstitute of Pathology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Bernd WullichDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Sven WachDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany.
Helge TaubertDepartment of Urology and Pediatric Urology, University Hospital Erlangen, FAU Erlangen-Nürnberg, Germany. helge.taubert@uk-erlangen.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Piwi-like proteins are essential for stem-cell maintenance and self-renewal in multicellular organisms. We analyzed the expression of Piwi-like 1 and Piwi-like 2 by immunohistochemistry (IHC) in 95 muscle invasive bladder cancer (MIBC) samples using tissue microarray. Application of an immunoreactive score (IRS) revealed 37 and 45 patients who were Piwi-like 1 and -2 positive (IRS > 2). IHC results were correlated with clinico-pathological and survival data. The expression of both proteins was positively correlated with each other, lymph node metastasis and expression of CK20 and GATA 3. A negative correlation for both proteins was detected for disease-specific survival (DSS), recurrence, Ki67/MIB1 proliferation index, and CK5 expression. Detection of Piwi-like 1 protein positivity was associated with poor DSS (P = 0.019; log rank test, Kaplan-Meier analysis), and in multivariate Cox's analysis (adjusted to tumor stage and tumor grade), it was an independent prognostic factor for DSS (RR = 2.16; P = 0.011). Piwi-like 2 positivity was associated with DSS (P = 0.008) and recurrence-free survival (RFS; P = 0.040), and in multivariate Cox's analysis, Piwi-like 2 positivity was an independent prognostic factor for DSS (RR = 2.46; P = 0.004) and RFS (RR = 3.0; P = 0.003). Most interestingly, in the basal type patient subgroup (CK5+/GATA3-), Piwi-like 2 positivity was associated with poorer DSS, OS and RFS (P < 0.001, P = 0.004 and P = 0.05; log rank test). In multivariate analysis, Piwi-like 2 positivity was an independent prognostic factor for DSS (RR = 12.70; P = 0.001), OS (RR = 6.62;  = 0.008) and RFS (RR=13.0; P = 0.040). In summary, Piwi-like 1 and -2 positivity are associated with clinico-pathological factors and survival. Both Piwi-like proteins are suggested as biomarkers for MIBC patients.

Indexed as

AdultAgedAged, 80 and overArgonaute ProteinsBiomarkers, TumorDisease-Free SurvivalFemaleGATA3 Transcription FactorHumansImmunohistochemistryKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedMusclesNeoplasm InvasivenessArgonaute ProteinsBiomarkers, TumorGATA3 Transcription FactorPIWIL1 protein, humanPIWIL2 protein, human

Identifiers

PMID30523270
PMCPMC6283838
OpenAlexW2902528465

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.